ArticleFrontiers in pharmacology2026

Rituximab with low-dose glucocorticoids for treating refractory membranous nephropathy: a prospective single-center cohort study.

Youqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.